Download PDF
Zeitschrift für Komplementärmedizin 2018; 10(06): 42-45
DOI: 10.1055/a-0772-1259
Wissen
Heilpflanze
© Karl F. Haug Verlag in MVS Medizinverlage Stuttgart GmbH & Co. KG

Weißdorn

Sigrun Chrubasik-Hausmann
Subject Editor:
Further Information

Publication History

Publication Date:
18 December 2018 (online)

    Permissions and Reprints

Summary

Crataegus – wirksam bei Herzschwäche

Keywords

Heilpflanze - Weißdorn - Herzerkrankung - Herzinsuffizienz - kardiovaskuläre Erkrankung
 

  • Literatur

  • 1 Arslan R, Bektas N, Bor Z. et al Evaluation of the antithrombotic effects of Crataegus monogyna and Crataegus davisii in the carrageenan-induced tail thrombosis model.. Pharm Biol 2015; 53: 275-279
    CrossrefPubMedGoogle Scholar
  • 2 Bedreag CF, Trifan A, Vasincu A. et al In vitro screening of Crataegus succulenta extracts for free radical scavenging and 15-lipoxygenase inhibitory activities.. Rev Med Chir Soc Med Nat Iasi 2014; 118: 544-550
    PubMedGoogle Scholar
  • 3 Belkhir M, Rebai O, Dhaouadi K. et al Comparative analysis of Tunisian wild Crataegus azarolus (yellow azarole) and Crataegus monogyna (red azarole) leaf, fruit, and traditionally derived syrup: phenolic profiles and antioxidant and antimicrobial activities of the aqueous-acetone extracts.. J Agric Food Chem 2013; 61: 9594-9601
    PubMedGoogle Scholar
  • 4 Belščak-Cvitanović A, Durgo K, Bušić A. et al Phytochemical attributes of four conventionally extracted medicinal plants and cytotoxic evaluation of their extracts on human laryngeal carcinoma (HEp2) cells.. J Med Food 2014; 17: 206-217
    CrossrefPubMedGoogle Scholar
  • 5 Benmalek Y, Yahia OA, Belkebir A. et al Anti-microbial and anti-oxidant activities of Illicium verum, Crataegus oxyacantha ssp monogyna and Allium cepa red and white varieties.. Bioengineered 2013; 4: 244-248
    CrossrefPubMedGoogle Scholar
  • 6 Blaschek W, Hilgenfeldt U, Holzgrabe U. et al Hagers Enzyklopädie der Arzneistoffe und Drogen.. Stuttgart: Wissenschaftliche Verlagsgesellschaft; 2016
    Google Scholar
  • 7 Cheng N, Wang Y, Gao H. et al Protective effect of extract of Crataegus pinnatifida pollen on DNA damage response to oxidative stress.. Food Chem Toxicol 2013; 59: 709-714
    CrossrefPubMedGoogle Scholar
  • 8 Fu JH, Zheng YQ, Li P. et al Hawthorn leaves flavonoids decreases inflammation related to acute myocardial ischemia/reperfusion in anesthetized dogs.. Chin J Integr Med 2013; 19: 582-588
    CrossrefPubMedGoogle Scholar
  • 9 Ganie SA, Dar TA, Zargar B. et al Antioxidant and hepatoprotective effects of Crataegus songarica methanol extract.. J Environ Pathol Toxicol Oncol 2014; 33: 131-143
    CrossrefPubMedGoogle Scholar
  • 10 Hernández-Pérez A, Bah M, Ibarra-Alvarado C. et al. Aortic relaxant activity of Crataegus gracilior Phipps and identification of some of its chemical constituents.. Molecules 2014; 19: 20962-20974
    CrossrefPubMedGoogle Scholar
  • 11 Holubarsch CJF, Colucci WS, Eha J. Benefit-Risk Assessment of Crataegus Extract WS 1442: An Evidence-Based Review.. Am J Cardiovasc Drugs 2018; 18: 25-36
    CrossrefPubMedGoogle Scholar
  • 12 Idris-Khodja N, Auger C, Koch E. et al Crataegus special extract WS(®)1442 prevents aging-related endothelial dysfunction.. Phytomedicine 2012; 19: 699-706
    CrossrefPubMedGoogle Scholar
  • 13 Ku SK, Kwak S, Kwon OJ. et al Hyperoside inhibits high-glucose-induced vascular inflammation in vitro and in vivo.. Inflammation 2014; 37: 1389-1400
    CrossrefPubMedGoogle Scholar
  • 14 Littleton RM, Miller M, Hove JR. Whole plant based treatment of hypercholesterolemia with Crataegus laevigata in a zebrafish model.. BMC Complement Altern Med 2012; 12: 105
    CrossrefPubMedGoogle Scholar
  • 15 Lucconi G, Chlapanidas T, Martino E. et al Formulation of microspheres containing Crataegus monogyna Jacq. extract with free radical scavenging activity.. Pharm Dev Technol 2014; 19: 65-72
    CrossrefPubMedGoogle Scholar
  • 16 Mustapha N, Bouhlel I, Chaabane F. et al Aqueous extract of Crataegus azarolus protects against DNA damage in human lymphoblast Cell K562 and enhances antioxidant activity.. Appl Biochem Biotechnol 2014; 172: 2266-2275
    CrossrefPubMedGoogle Scholar
  • 17 Mustapha N, Bzéouich IM, Ghedira K. et al Compounds isolated from the aerial part of Crataegus azarolus inhibit growth of B16F10 melanoma cells and exert a potent inhibition of the melanin synthesis.. Biomed Pharmacother 2015; 69: 139-144
    CrossrefPubMedGoogle Scholar
  • 18 Niu Y, Nan Y, Yuan L. et al Study on antibacterial effect of medlar and hawthorn compound extract in vitro.. Afr J Tradit Complement Altern Med 2013; 10: 567-573
    PubMedGoogle Scholar
  • 19 Sharifi N, Souri E, Ziai SA. et al Discovery of new angiotensin converting enzyme (ACE) inhibitors from medicinal plants to treat hypertension using an in vitro assay.. Daru 2013; 21: 74
    CrossrefPubMedGoogle Scholar
  • 20 Shatoor AS. In vivo hemodynamic and electrocardiographic changes following Crataegus aronia syn. Azarolus L administration to normotensive Wistar rats.. Saudi Med J 2013; 34: 123-134
    PubMedGoogle Scholar
  • 21 Shih CC, Lin CH, Lin YJ. et al Validation of the Antidiabetic and Hypolipidemic Effects of hawthorn by assessment of gluconeogenesis and lipogenesis related genes and AMP-activated protein kinase phosphorylation.. Evid Based Complement Alternat Med 2013; 2013: 597067
    PubMedGoogle Scholar
  • 22 Shortle E, O&Grady MN, Gilroy D. et al Influence of extraction technique on the anti-oxidative potential of hawthorn (Crataegus monogyna) extracts in bovine muscle homogenates.. Meat Sci 2014; 98: 828-834
    CrossrefPubMedGoogle Scholar
  • 23 Song SJ, Li LZ, Gao PY. et al Isolation of antithrombotic phenolic compounds from the leaves of Crataegus pinnatifida.. Planta Med 2012; 78: 1967-1971
    Article in Thieme ConnectPubMedGoogle Scholar
  • 24 Sun J, Gao G, Gao Y. et al Experimental research on the in vitro antitumor effects of Crataegus sanguinea.. Cell Biochem Biophys 2013; 67: 207-213
    CrossrefPubMedGoogle Scholar
  • 25 Wang X, Liang Y, Shi J. et al Crataegus special extract WS 1442 effects on eNOS and microRNA 155.. Planta Med 2018; 84 (015) 1094-1100
    Article in Thieme ConnectPubMedGoogle Scholar
  • 26 European Medicines Agency. European Union list entry on Crataegus spp., folium cum flore (28.01.2015) Im Internet: www.ema.europa.eu/docs/en_GB/document_library/Herbal_-_Community_List_Entry/2015/02/WC500181936.pdf;Stand:22.10.2018
  • 27 European Medicines Agency. Assessment report on Crataegus spp., folium cum flore (13.10.2014). Im Internet: www.ema.europa.eu/docs/en_GB/document_library/Herbal_-_HMPC_assessment_report/2014/10/WC500175526.pdf;Stand:22.10.2018
  • 28 Wei W, Ying X, Zhang W. et al Effects of vitexin-2"-O-rhamnoside and vitexin-4"-O-glucoside on growth and oxidative stress-induced cell apoptosis of human adipose-derived stem cells.. J Pharm Pharmacol 2014; 66: 988-997
    CrossrefPubMedGoogle Scholar
  • 29 Zhang Y, Zhang L, Geng Y. et al Hawthorn fruit attenuates atherosclerosis by improving the hypolipidemic and antioxidant activities in apolipoprotein e-deficient mice.. J Atheroscler Thromb 2014; 21: 119-128
    CrossrefPubMedGoogle Scholar
  • 30 Zick SM, Vautaw BM, Gillespie B. et al Hawthorn extract randomized blinded chronic heart failure (HERB CHF) trial.. Eur J Heart Fail 2009; 11: 990-999
    CrossrefPubMedGoogle Scholar
  • 31 Zorniak M, Szydlo B, Krzeminski TF. Crataegus special extract WS 1442: up-to-date review of experimental and clinical experiences.. J Physiol Pharmacol 2017; 68: 521-526
    Google Scholar